Funds › Altrius Capital Management Inc
Altrius Capital Management Inc
13F for Q3 2026, filed Nov 5, 2026. 91 positions worth $561.0M.Managers with more than $100 million in US-listed stocks list their holdings each quarter, within 45 days of quarter end. Long positions only: no short sales or cash.
Ask your AI about this
Connect Claude, ChatGPT, Gemini or Grok (Microsoft 365 Copilot coming soon) to 13F.ai and ask in plain English. Copy a question to get started:
Using 13F.ai, what are the biggest new, added, trimmed and exited positions of Altrius Capital Management Inc in the latest 13F quarter?
Using 13F.ai, how has Altrius Capital Management Inc's portfolio concentration changed over the last four quarters?
Using 13F.ai, which of Altrius Capital Management Inc's top holdings have also been bought by insiders recently?
Connect your AI · Plans and the 7-day free trial (card required)
Holdings, Q3 2026
Largest first. Common shares only; puts and calls are under All positions.
| # | The fund's own figures at the end of the quarter. A report can be up to 45 days old when it is filed. Options and bonds are not counted here. | Filing | ||||
|---|---|---|---|---|---|---|
| 1 | RY Royal Bank of Canada | 67,391 | $13.2M | 2.4% | +1.4% | 13F ↗ |
| 2 | Dhl AG - ADR | 379,431 | $12.2M | 2.2% | +8.8% | 13F ↗ |
| 3 | NXPI NXP Semiconductors N.V. | 50,852 | $12.1M | 2.2% | +43.0% | 13F ↗ |
| 4 | BP BP p.l.c. · ADR | 272,751 | $12.0M | 2.1% | +5.0% | 13F ↗ |
| 5 | Siemens Ag-Spons ADR American Depositary Shares | 75,855 | $11.8M | 2.1% | +7.2% | 13F ↗ |
| 6 | Capgemini SE - Unsponsor ADR | 491,889 | $11.6M | 2.1% | +9.5% | 13F ↗ |
| 7 | TTE TotalEnergies SE · Act | 134,426 | $11.5M | 2.0% | +3.8% | 13F ↗ |
| 8 | Reckitt Benck Grp Sponsored Ad ADR | 856,719 | $11.4M | 2.0% | +10.8% | 13F ↗ |
| 9 | Muenchener Rueck-Unspon ADR | 1.01M | $11.4M | 2.0% | +21.5% | 13F ↗ |
| 10 | ABEV Ambev S.A. · ADR | 3.88M | $11.3M | 2.0% | +5.5% | 13F ↗ |
| 11 | BBVA Banco Bilbao Vizcaya Argentaria S.A. · ADR | 403,071 | $11.2M | 2.0% | -15.6% | 13F ↗ |
| 12 | Axa -Spons ADR ADR | 232,643 | $11.1M | 2.0% | +11.9% | 13F ↗ |
| 13 | TM Toyota Motor Corporation | 60,760 | $11.1M | 2.0% | +5.2% | 13F ↗ |
| 14 | AZN AstraZeneca PLC | 68,573 | $11.1M | 2.0% | +18.2% | 13F ↗ |
| 15 | Roche Holdings Ltd-Spons ADR | 212,885 | $11.0M | 2.0% | +11.9% | 13F ↗ |
| 16 | BAESY Bae Systems plc -Spon ADR · Adus | 106,202 | $11.0M | 2.0% | +8.8% | 13F ↗ |
| 17 | NVS Novartis AG · ADR | 77,180 | $11.0M | 2.0% | +6.3% | 13F ↗ |
| 18 | Bnp Paribas-Adr Adus | 205,250 | $11.0M | 2.0% | +7.6% | 13F ↗ |
| 19 | LYB LyondellBasell Industries NV · Shs - A - | 186,366 | $10.7M | 1.9% | +14.4% | 13F ↗ |
| 20 | GSK GSK plc · ADR | 221,868 | $10.7M | 1.9% | +8.5% | 13F ↗ |
| 21 | Publicis Groupe-Adr Adus | 397,909 | $10.7M | 1.9% | -8.9% | 13F ↗ |
| 22 | BTI British American Tobacco p.l.c. · ADR | 194,112 | $10.6M | 1.9% | +11.3% | 13F ↗ |
| 23 | SNY Sanofi | 254,678 | $10.5M | 1.9% | +6.7% | 13F ↗ |
| 24 | Nestle Sa-Spons ADR | 114,550 | $10.4M | 1.9% | +17.4% | 13F ↗ |
| 25 | Vinci S.a.-Unspons ADR ADR | 343,724 | $10.3M | 1.8% | +23.2% | 13F ↗ |
| 26 | PM Philip Morris International Inc | 45,324 | $8.6M | 1.5% | +2.7% | 13F ↗ |
| 27 | MRK Merck & Company, Inc. | 53,198 | $7.7M | 1.4% | -2.7% | 13F ↗ |
| 28 | MSM MSC Industrial Direct Company, Inc. | 60,061 | $7.4M | 1.3% | -3.5% | 13F ↗ |
| 29 | JNJ Johnson & Johnson | 27,595 | $7.3M | 1.3% | -0.2% | 13F ↗ |
| 30 | GILD Gilead Sciences, Inc. | 48,296 | $7.2M | 1.3% | +3.6% | 13F ↗ |
| 31 | STT State Street Corporation | 41,200 | $7.2M | 1.3% | -7.0% | 13F ↗ |
| 32 | CVX Chevron Corporation | 34,859 | $7.1M | 1.3% | +2.9% | 13F ↗ |
| 33 | Ea Series Trust Altrius Gbl Div | 166,226 | $7.1M | 1.3% | +7.6% | 13F ↗ |
| 34 | ABBV AbbVie Inc. | 27,039 | $7.1M | 1.3% | +2.2% | 13F ↗ |
| 35 | XOM ExxonMobil Holdings Corporation | 43,339 | $7.1M | 1.3% | +0.7% | 13F ↗ |
| 36 | MO Altria Group, Inc. | 103,526 | $7.0M | 1.2% | +4.3% | 13F ↗ |
| 37 | BEN Franklin Templeton, Inc. | 214,703 | $6.9M | 1.2% | -3.6% | 13F ↗ |
| 38 | C Citigroup, Inc. | 52,667 | $6.8M | 1.2% | +2.0% | 13F ↗ |
| 39 | JPM JPMorgan Chase & Co. | 20,315 | $6.7M | 1.2% | +2.9% | 13F ↗ |
| 40 | ABT Abbott Laboratories | 67,761 | $6.7M | 1.2% | +1.7% | 13F ↗ |
| 41 | PFE Pfizer, Inc. | 234,129 | $6.7M | 1.2% | +8.1% | 13F ↗ |
| 42 | BXP BXP, Inc. | 103,766 | $6.3M | 1.1% | +1.4% | 13F ↗ |
| 43 | CME CME Group Inc. | 24,085 | $6.3M | 1.1% | New | 13F ↗ |
| 44 | MDT Medtronic plc. | 72,981 | $6.3M | 1.1% | +4.1% | 13F ↗ |
| 45 | UNH UnitedHealth Group Incorporated | 17,146 | $6.3M | 1.1% | -5.7% | 13F ↗ |
| 46 | VZ Verizon Communications Inc. | 137,082 | $6.3M | 1.1% | +4.7% | 13F ↗ |
| 47 | BAC Bank of America Corporation | 114,475 | $6.2M | 1.1% | +2.8% | 13F ↗ |
| 48 | KO Coca-Cola Company | 72,219 | $6.2M | 1.1% | +4.7% | 13F ↗ |
| 49 | SBUX Starbucks Corporation | 65,694 | $6.2M | 1.1% | +5.6% | 13F ↗ |
| 50 | LMT Lockheed Martin Corporation | 11,997 | $6.1M | 1.1% | +6.7% | 13F ↗ |
Changes since Q2 2026
4 new, 63 added to, 21 trimmed, 2 exited, 3 unchanged. By estimated dollars.
New positions (4)
Added to (63)
| NXPI NXP Semiconductors N.V. | 50,852 | +43.0% | $3.6M |
| AAPL Apple Inc. | 12,785 | +111% | $2.2M |
| Muenchener Rueck-Unspon ADR | 1.01M | +21.5% | $2.0M |
| Vinci S.a.-Unspons ADR ADR | 343,724 | +23.2% | $1.9M |
| AZN AstraZeneca PLC | 68,573 | +18.2% | $1.7M |
| Nestle Sa-Spons ADR | 114,550 | +17.4% | $1.5M |
| LYB LyondellBasell Industries NV · Shs - A - | 186,366 | +14.4% | $1.3M |
| Axa -Spons ADR ADR | 232,643 | +11.9% | $1.2M |
| Roche Holdings Ltd-Spons ADR | 212,885 | +11.9% | $1.2M |
| Reckitt Benck Grp Sponsored Ad ADR | 856,719 | +10.8% | $1.1M |
Trimmed (21)
| BBVA Banco Bilbao Vizcaya Argentaria S.A. · ADR | 403,071 | -15.6% | -$2.1M |
| Publicis Groupe-Adr Adus | 397,909 | -8.9% | -$1.0M |
| STT State Street Corporation | 41,200 | -7.0% | -$545.2K |
| UNH UnitedHealth Group Incorporated | 17,146 | -5.7% | -$382.5K |
| MSM MSC Industrial Direct Company, Inc. | 60,061 | -3.5% | -$268.1K |
| BEN Franklin Templeton, Inc. | 214,703 | -3.6% | -$256.6K |
| MRK Merck & Company, Inc. | 53,198 | -2.7% | -$214.0K |
| LLY Eli Lilly and Company | 1,136 | -3.2% | -$42.8K |
| Invesco Exch Trd Slf Idx Fd Invsco Blsh 26 | 49,218 | -3.1% | -$36.0K |
| Invesco Exch Trd Slf Idx Fd Invsco 28 Hycorp | 39,429 | -2.9% | -$25.2K |
The 10 largest of each, by estimated dollars: shares changed times the later report's price. Index tracking, splits and mergers move positions too.
All positions
Search, sort and filter every position, with puts and calls on their own tab. Premium plan.
Compare two quarters
Pick any two quarters: what is new, added to, trimmed or exited. Premium plan.
Reported value by quarter
Value and number of positions at the end of each quarter.
Loading…
Largest positions in earlier quarters
Pick a quarter to see what the fund's biggest positions were then.
Loading…
Ten largest positions
By value, Q3 2026.
Filings
| Filing | ||||||
|---|---|---|---|---|---|---|
| Q3 2026 | Nov 5, 2026 | 13F-HR | 91 | $561.0M | Current | SEC ↗ |
| Q2 2026 | Aug 13, 2026 | 13F-HR | 89 | $526.5M | Current | SEC ↗ |
| Q1 2026 | May 5, 2026 | 13F-HR | 87 | $502.5M | Current | SEC ↗ |
| Q4 2025 | Feb 2, 2026 | 13F-HR | 86 | $471.8M | Current | SEC ↗ |
| Q3 2025 | Nov 5, 2025 | 13F-HR | 85 | $438.4M | Current | SEC ↗ |
| Q2 2025 | Aug 6, 2025 | 13F-HR | 84 | $427.8M | Current | SEC ↗ |
| Q1 2025 | Apr 22, 2025 | 13F-HR | 86 | $411.4M | Current | SEC ↗ |
Most recent first, up to 80. An amendment can replace a report or add holdings to it. All 13F filings
Information, not investment advice. Values are the fund's own figures at quarter end; a report can be up to 45 days old when filed. Disclaimer